Literature DB >> 34241776

A Comprehensive Review of COVID-19 Virology, Vaccines, Variants, and Therapeutics.

Lauren Forchette1, William Sebastian1, Tuoen Liu2.   

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative pathogen of the coronavirus disease 2019 (COVID-19), has caused more than 179 million infections and 3.8 million deaths worldwide. Throughout the past year, multiple vaccines have already been developed and used, while some others are in the process of being developed. However, the emergence of new mutant strains of SARS-CoV-2 that have demonstrated immune-evading characteristics and an increase in infective capabilities leads to potential ineffectiveness of the vaccines against these variants. The purpose of this review article is to highlight the current understanding of the immunological mechanisms of the virus and vaccines, as well as to investigate some key variants and mutations of the virus driving the current pandemic and their impacts on current management guidelines. We also discussed new technologies being developed for the prevention, treatment, and detection of SARS-CoV-2. In this paper, we thoroughly reviewed and provided crucial information on SARS-CoV-2 virology, vaccines and drugs being used and developed for its prevention and treatment, as well as important variant strains. Our review paper will be beneficial to health care professionals and researchers so they can have a better understanding of the basic sciences, prevention, and clinical treatment of COVID-19 during the pandemic. This paper consists of the most updated information that has been available as of June 21, 2021.
© 2021. The Author(s).

Entities:  

Keywords:  antiviral therapy; coronavirus disease 2019; severe acute respiratory syndrome coronavirus 2; vaccines; variant strains

Mesh:

Substances:

Year:  2021        PMID: 34241776      PMCID: PMC8267225          DOI: 10.1007/s11596-021-2395-1

Source DB:  PubMed          Journal:  Curr Med Sci        ISSN: 2523-899X


  81 in total

Review 1.  Antibody-dependent enhancement and SARS-CoV-2 vaccines and therapies.

Authors:  Wen Shi Lee; Adam K Wheatley; Stephen J Kent; Brandon J DeKosky
Journal:  Nat Microbiol       Date:  2020-09-09       Impact factor: 17.745

2.  Targeting inflammation and cytokine storm in COVID-19.

Authors:  Qianwen Huang; Xiumei Wu; Xueying Zheng; Sihui Luo; Suowen Xu; Jianping Weng
Journal:  Pharmacol Res       Date:  2020-06-27       Impact factor: 7.658

3.  A pneumonia outbreak associated with a new coronavirus of probable bat origin.

Authors:  Peng Zhou; Xing-Lou Yang; Xian-Guang Wang; Ben Hu; Lei Zhang; Wei Zhang; Hao-Rui Si; Yan Zhu; Bei Li; Chao-Lin Huang; Hui-Dong Chen; Jing Chen; Yun Luo; Hua Guo; Ren-Di Jiang; Mei-Qin Liu; Ying Chen; Xu-Rui Shen; Xi Wang; Xiao-Shuang Zheng; Kai Zhao; Quan-Jiao Chen; Fei Deng; Lin-Lin Liu; Bing Yan; Fa-Xian Zhan; Yan-Yi Wang; Geng-Fu Xiao; Zheng-Li Shi
Journal:  Nature       Date:  2020-02-03       Impact factor: 69.504

4.  SARS-CoV-2 D614G spike mutation increases entry efficiency with enhanced ACE2-binding affinity.

Authors:  Seiya Ozono; Yanzhao Zhang; Hirotaka Ode; Kaori Sano; Toong Seng Tan; Kazuo Imai; Kazuyasu Miyoshi; Satoshi Kishigami; Takamasa Ueno; Yasumasa Iwatani; Tadaki Suzuki; Kenzo Tokunaga
Journal:  Nat Commun       Date:  2021-02-08       Impact factor: 14.919

5.  SARS-CoV-2 spike variants exhibit differential infectivity and neutralization resistance to convalescent or post-vaccination sera.

Authors:  Alona Kuzmina; Yara Khalaila; Olga Voloshin; Ayelet Keren-Naus; Liora Boehm-Cohen; Yael Raviv; Yonat Shemer-Avni; Elli Rosenberg; Ran Taube
Journal:  Cell Host Microbe       Date:  2021-03-20       Impact factor: 21.023

6.  Antibody evasion by the P.1 strain of SARS-CoV-2.

Authors:  Wanwisa Dejnirattisai; Daming Zhou; Piyada Supasa; Chang Liu; Alexander J Mentzer; Helen M Ginn; Yuguang Zhao; Helen M E Duyvesteyn; Aekkachai Tuekprakhon; Rungtiwa Nutalai; Beibei Wang; César López-Camacho; Jose Slon-Campos; Thomas S Walter; Donal Skelly; Sue Ann Costa Clemens; Felipe Gomes Naveca; Valdinete Nascimento; Fernanda Nascimento; Cristiano Fernandes da Costa; Paola Cristina Resende; Alex Pauvolid-Correa; Marilda M Siqueira; Christina Dold; Robert Levin; Tao Dong; Andrew J Pollard; Julian C Knight; Derrick Crook; Teresa Lambe; Elizabeth Clutterbuck; Sagida Bibi; Amy Flaxman; Mustapha Bittaye; Sandra Belij-Rammerstorfer; Sarah C Gilbert; Miles W Carroll; Paul Klenerman; Eleanor Barnes; Susanna J Dunachie; Neil G Paterson; Mark A Williams; David R Hall; Ruben J G Hulswit; Thomas A Bowden; Elizabeth E Fry; Juthathip Mongkolsapaya; Jingshan Ren; David I Stuart; Gavin R Screaton
Journal:  Cell       Date:  2021-03-30       Impact factor: 41.582

7.  Two Different Antibody-Dependent Enhancement (ADE) Risks for SARS-CoV-2 Antibodies.

Authors:  Darrell O Ricke
Journal:  Front Immunol       Date:  2021-02-24       Impact factor: 7.561

8.  Plitidepsin has potent preclinical efficacy against SARS-CoV-2 by targeting the host protein eEF1A.

Authors:  Kris M White; Romel Rosales; Soner Yildiz; Thomas Kehrer; Lisa Miorin; Elena Moreno; Sonia Jangra; Melissa B Uccellini; Raveen Rathnasinghe; Lynda Coughlan; Carles Martinez-Romero; Jyoti Batra; Ajda Rojc; Mehdi Bouhaddou; Jacqueline M Fabius; Kirsten Obernier; Marion Dejosez; María José Guillén; Alejandro Losada; Pablo Avilés; Michael Schotsaert; Thomas Zwaka; Marco Vignuzzi; Kevan M Shokat; Nevan J Krogan; Adolfo García-Sastre
Journal:  Science       Date:  2021-01-25       Impact factor: 47.728

Review 9.  The trinity of COVID-19: immunity, inflammation and intervention.

Authors:  Matthew Zirui Tay; Chek Meng Poh; Laurent Rénia; Paul A MacAry; Lisa F P Ng
Journal:  Nat Rev Immunol       Date:  2020-04-28       Impact factor: 108.555

Review 10.  Angiotensin-Converting Enzyme 2: SARS-CoV-2 Receptor and Regulator of the Renin-Angiotensin System: Celebrating the 20th Anniversary of the Discovery of ACE2.

Authors:  Mahmoud Gheblawi; Kaiming Wang; Anissa Viveiros; Quynh Nguyen; Jiu-Chang Zhong; Anthony J Turner; Mohan K Raizada; Maria B Grant; Gavin Y Oudit
Journal:  Circ Res       Date:  2020-04-08       Impact factor: 17.367

View more
  20 in total

Review 1.  Biological Properties of SARS-CoV-2 Variants: Epidemiological Impact and Clinical Consequences.

Authors:  Reem Hoteit; Hadi M Yassine
Journal:  Vaccines (Basel)       Date:  2022-06-09

2.  An extended picture fuzzy multicriteria group decision analysis with different weights: A case study of COVID-19 vaccine allocation.

Authors:  Tarifa Almulhim; Igor Barahona
Journal:  Socioecon Plann Sci       Date:  2022-09-24       Impact factor: 4.641

3.  Effect of Omicron on the prevalence of COVID-19 in international travelers at the Mexico city international airport. December 16th, 2021 to January 31st, 2022.

Authors:  Gustavo Olaiz-Fernández; Félix Jesús Vicuña de Anda; Jorge-Baruch Diaz-Ramirez; German E Fajardo Dolci; Patricia Bautista-Carbajal; Antonio Humberto Angel-Ambrocio; Miguel Leonardo García-León; Elena Gómez Peña; Jorge Alejandro Camacho Morales; Rosa Maria Wong-Chew
Journal:  Travel Med Infect Dis       Date:  2022-05-29       Impact factor: 20.441

4.  A systematic review of Vaccine Breakthrough Infections by SARS-CoV-2 Delta Variant.

Authors:  Mengxin Zhang; Ying Liang; Dongsheng Yu; Bang Du; Weyland Cheng; Lifeng Li; Zhidan Yu; Shuying Luo; Yaodong Zhang; Huanmin Wang; Xianwei Zhang; Wancun Zhang
Journal:  Int J Biol Sci       Date:  2022-01-01       Impact factor: 6.580

Review 5.  Cytokine storm in COVID-19: from viral infection to immune responses, diagnosis and therapy.

Authors:  Yizhou Jiang; Limor Rubin; Tangming Peng; Linlin Liu; Xingan Xing; Philip Lazarovici; Wenhua Zheng
Journal:  Int J Biol Sci       Date:  2022-01-01       Impact factor: 6.580

Review 6.  The Role of Micronutrients to Support Immunity for COVID-19 Prevention.

Authors:  Mukhtar H Ahmed; Arez Hassan; Judit Molnár
Journal:  Rev Bras Farmacogn       Date:  2021-09-02       Impact factor: 2.010

7.  Teaching during COVID-19 pandemic in practical laboratory classes of applied biochemistry and pharmacology: A validated fast and simple protocol for detection of SARS-CoV-2 Spike sequences.

Authors:  Jessica Gasparello; Chiara Papi; Matteo Zurlo; Lucia Carmela Cosenza; Giulia Breveglieri; Cristina Zuccato; Roberto Gambari; Alessia Finotti
Journal:  PLoS One       Date:  2022-04-06       Impact factor: 3.752

8.  Sustainable materials and COVID-19 detection biosensor: A brief review.

Authors:  Sora Yasri; Viroj Wiwanitkit
Journal:  Sens Int       Date:  2022-03-09

Review 9.  Healthy Immunity on Preventive Medicine for Combating COVID-19.

Authors:  Pulak R Manna; Zackery C Gray; P Hemachandra Reddy
Journal:  Nutrients       Date:  2022-02-27       Impact factor: 5.717

10.  Myocarditis, Pericarditis and Cardiomyopathy After COVID-19 Vaccination.

Authors:  Salvatore Pepe; Ann T Gregory; A Robert Denniss
Journal:  Heart Lung Circ       Date:  2021-07-30       Impact factor: 2.975

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.